BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 26596863)

  • 1. Virulence factors of Clostridium difficile and their role during infection.
    Janoir C
    Anaerobe; 2016 Feb; 37():13-24. PubMed ID: 26596863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clostridium difficile Adhesins.
    Péchiné S; Denève-Larrazet C; Collignon A
    Methods Mol Biol; 2016; 1476():91-101. PubMed ID: 27507335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase variation of Clostridium difficile virulence factors.
    Anjuwon-Foster BR; Tamayo R
    Gut Microbes; 2018 Jan; 9(1):76-83. PubMed ID: 28806147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of the virulence of a non-RT027, non-RT078 and binary toxin-positive Clostridium difficile strain associated with severe diarrhea.
    Li C; Harmanus C; Zhu D; Meng X; Wang S; Duan J; Liu S; Fu C; Zhou P; Liu R; Wu A; Kuijper EJ; Smits WK; Fu L; Sun X
    Emerg Microbes Infect; 2018 Dec; 7(1):211. PubMed ID: 30542069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Type IV Pili Promote Clostridium difficile Adherence and Persistence in a Mouse Model of Infection.
    McKee RW; Aleksanyan N; Garrett EM; Tamayo R
    Infect Immun; 2018 May; 86(5):. PubMed ID: 29483294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Defining the Roles of TcdA and TcdB in Localized Gastrointestinal Disease, Systemic Organ Damage, and the Host Response during Clostridium difficile Infections.
    Carter GP; Chakravorty A; Pham Nguyen TA; Mileto S; Schreiber F; Li L; Howarth P; Clare S; Cunningham B; Sambol SP; Cheknis A; Figueroa I; Johnson S; Gerding D; Rood JI; Dougan G; Lawley TD; Lyras D
    mBio; 2015 Jun; 6(3):e00551. PubMed ID: 26037121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clostridium difficile spores and its relevance in the persistence and transmission of the infection].
    Barra-Carrasco J; Hernández-Rocha C; Ibáñez P; Guzmán-Durán AM; Álvarez-Lobos M; Paredes-Sabja D
    Rev Chilena Infectol; 2014 Dec; 31(6):694-703. PubMed ID: 25679927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clostridium difficile virulence factors: Insights into an anaerobic spore-forming pathogen.
    Awad MM; Johanesen PA; Carter GP; Rose E; Lyras D
    Gut Microbes; 2014; 5(5):579-93. PubMed ID: 25483328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcome of relapsing Clostridium difficile infections do not correlate with virulence-, spore- and vegetative cell-associated phenotypes.
    Plaza-Garrido Á; Miranda-Cárdenas C; Castro-Córdova P; Olguín-Araneda V; Cofré-Araneda G; Hernández-Rocha C; Carman R; Ibáñez P; Fawley WN; Wilcox MH; Gil F; Calderón IL; Fuentes JA; Guzmán-Durán AM; Alvarez-Lobos M; Paredes-Sabja D
    Anaerobe; 2015 Dec; 36():30-8. PubMed ID: 26403333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of Type IV Pili Contributes to Surface Behaviors of Historical and Epidemic Strains of Clostridium difficile.
    Purcell EB; McKee RW; Bordeleau E; Burrus V; Tamayo R
    J Bacteriol; 2016 Feb; 198(3):565-77. PubMed ID: 26598364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New trends in Clostridium difficile virulence and pathogenesis.
    Denève C; Janoir C; Poilane I; Fantinato C; Collignon A
    Int J Antimicrob Agents; 2009 Mar; 33 Suppl 1():S24-8. PubMed ID: 19303565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune responses induced by Clostridium difficile.
    Péchiné S; Collignon A
    Anaerobe; 2016 Oct; 41():68-78. PubMed ID: 27108093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Investigation of toxin genes of Clostridium difficile strains isolated from hospitalized patients with diarrhoea at Marmara University Hospital].
    Deniz U; Ulger N; Aksu B; Karavuş M; Söyletir G
    Mikrobiyol Bul; 2011 Jan; 45(1):1-10. PubMed ID: 21341153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CdtR Regulates TcdA and TcdB Production in Clostridium difficile.
    Lyon SA; Hutton ML; Rood JI; Cheung JK; Lyras D
    PLoS Pathog; 2016 Jul; 12(7):e1005758. PubMed ID: 27414650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In silico, in vitro and in vivo analysis of putative virulence factors identified in large clostridial toxin-negative, binary toxin- producing C. difficile strains.
    Androga GO; Knight DR; Hutton ML; Mileto SJ; James ML; Evans C; Lyras D; Chang BJ; Foster NF; Riley TV
    Anaerobe; 2019 Dec; 60():102083. PubMed ID: 31377188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclic Diguanylate Regulates Virulence Factor Genes via Multiple Riboswitches in
    McKee RW; Harvest CK; Tamayo R
    mSphere; 2018 Oct; 3(5):. PubMed ID: 30355665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New perspectives in Clostridium difficile disease pathogenesis.
    Monaghan TM
    Infect Dis Clin North Am; 2015 Mar; 29(1):1-11. PubMed ID: 25573674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The second messenger cyclic Di-GMP regulates Clostridium difficile toxin production by controlling expression of sigD.
    McKee RW; Mangalea MR; Purcell EB; Borchardt EK; Tamayo R
    J Bacteriol; 2013 Nov; 195(22):5174-85. PubMed ID: 24039264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a recombinant toxin fragment vaccine for Clostridium difficile infection.
    Karczewski J; Zorman J; Wang S; Miezeiewski M; Xie J; Soring K; Petrescu I; Rogers I; Thiriot DS; Cook JC; Chamberlin M; Xoconostle RF; Nahas DD; Joyce JG; Bodmer JL; Heinrichs JH; Secore S
    Vaccine; 2014 May; 32(24):2812-8. PubMed ID: 24662701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Binary Clostridium difficile toxin (CDT) - A virulence factor disturbing the cytoskeleton.
    Aktories K; Papatheodorou P; Schwan C
    Anaerobe; 2018 Oct; 53():21-29. PubMed ID: 29524654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.